Fabio Zattoni, Leonor J Paulino Pereira, Giancarlo Marra, Massimo Valerio, Jonathan Olivier, Ignacio Puche-Sanz, Pawel Rajwa, Martina Maggi, Riccardo Campi, Daniele Amparore, Sabrina De Cillis, Zhuang Junlong, Hongqian Guo, Giulia La Bombarda, Andrea Fuschi, Alessandro Veccia, Francesco Ditonno, Alessandro Marquis, Francesco Barletta, Riccardo Leni, Sergio Serni, Veeru Kasivisvanathan, Alessandro Antonelli, Fabrizio Dal Moro, Juan Gomez Rivas, Roderick C N van den Bergh, Alberto Briganti, Giorgio Gandaglia, Giacomo Novara
OBJECTIVE: To evaluate the proportions of detected prostate cancer (PCa) and clinically significant PCa (csPCa), as well as identify clinical predictors of PCa, in patients with PI-RADS > = 3 lesion at mpMRI and initial negative targeted and systematic biopsy (initial biopsy) who underwent a second MRI and a re-biopsy. METHODS: A total of 290 patients from 10 tertiary referral centers were included. The primary outcome measures were the presence of PCa and csPCa at re-biopsy...
September 27, 2023: World Journal of Urology